what is the mechanism of action of glp 1 agonists GLP-1 The activity of GLP-1 and
Description
Increasing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) raises concern for interactions with warfarin
This Comment highlights emerging evidence and advocates for clinical strategies that prioritize muscle preservation to ensure the long-term success and safety of pharmacological weight management.
Over time, some patients may need to pause or stop therapy due to side effects, plateaus, or changing goals
Identification of the top 10 drugs linked to IGE
For complete coverage of all related areas of Endocrinology, please visit our on-line FREE web-text, WWW.ENDOTEXT.ORG.
